Lantern Pharma Company

Lantern Pharma is an oncology-focused, emerging, clinical stage pharma leveraging Artificial Intelligence, Genomics, and Machine Learning to transform the cost, pace, and timeline of drug discovery and development.

Last Funding Type: Series D
Funding Status: IPO
Headquarters: Dallas, Texas, United States
Founded Date: 2013-01-01
Last Funding Date: 2021-01-14
Total Funding: 50085302
Technology: ['BioTech & HealthTech']
Employee Number: 11-50
Estimated Revenue: $0.068B
Investors Number: 4
Industry: Biotechnology company